Skip to main content

Astellas DRC Phase 1b, Dose Escalation Evaluation of Safety and Tolerability and a Ph 2, Randomized, Parallel Group, Controlled, Proof of Concept Investigation of Efficacy and Safety of ASP7317 for Atrophy Secondary to AMD

Research Grant
Duke Scholars

Administered By

Ophthalmology

Awarded By

Astellas Institute for Regenerative Medicine

Start Date

March 30, 2017

End Date

April 30, 2021
 

Administered By

Ophthalmology

Awarded By

Astellas Institute for Regenerative Medicine

Start Date

March 30, 2017

End Date

April 30, 2021